AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionANCORA TRUST - Ancora Dividend Value Equity Fund Class I
Latest Disclosed Ownership12,219 shares
Latest Disclosed Value $ 2,268,090
ANCORA TRUST - Ancora Dividend Value Equity Fund Class I ownership in ABBV / AbbVie Inc.

On August 20, 2025 - ANCORA TRUST - Ancora Dividend Value Equity Fund Class I filed a NPORT-P form disclosing ownership of 12,219 shares of AbbVie Inc. (US:ABBV) valued at $2,268,091 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 12,219 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $2,776,523 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-20 2025-06-30 NP AbbVie EC US00287Y1091 12,219 0 0.00 2,268 -11.41 4.9200
2025-05-29 2025-03-31 NP AbbVie EC US00287Y1091 12,219 -1,148 -8.59 2,560 7.79 5.8800
2025-02-27 2024-12-31 NP AbbVie EC US00287Y1091 13,367 0 0.00 2,375 -10.00 5.3500
2024-11-25 2024-09-30 NP AbbVie EC US00287Y1091 13,367 0 0.00 2,640 15.14 5.9500
2024-08-20 2024-06-30 NP AbbVie EC US00287Y1091 13,367 0 0.00 2,293 -5.83 5.6300
2024-05-20 2024-03-31 NP AbbVie EC US00287Y1091 13,367 1,117 9.12 2,434 28.24 5.8900
2024-02-21 2023-12-31 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,898 4.00 4.8500
2023-10-31 2023-09-30 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,826 10.61 5.0400
2023-08-14 2023-06-30 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,650 -15.47 4.3100
2023-05-23 2023-03-31 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,952 -1.36 5.3900
2023-02-21 2022-12-31 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,980 20.38 5.3600
2022-11-25 2022-09-30 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,644 -12.37 5.0600
2022-08-22 2022-06-30 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,876 -5.49 5.5100
2022-05-25 2022-03-31 NP AbbVie EC US00287Y1091 12,250 0 0.00 1,986 19.72 5.4100
2022-02-28 2021-12-31 NP AbbVie EC US00287Y1091 12,250 3,000 32.43 1,659 66.30 4.4000
2021-11-29 2021-09-30 NP AbbVie EC US00287Y1091 9,250 1,410 17.98 998 12.91 3.0000
2021-08-25 2021-06-30 NP AbbVie EC US00287Y1091 7,840 0 0.00 883 4.13 2.7300
2021-05-27 2021-03-31 NP AbbVie EC US00287Y1091 7,840 0 0.00 848 0.95 2.7600
2021-02-19 2020-12-31 NP AbbVie EC US00287Y1091 7,840 2,240 40.00 840 71.43 2.9100
2020-11-25 2020-09-30 NP AbbVie EC US00287Y1091 5,600 440 8.53 491 24.68 1.9900
2020-05-29 2020-03-31 NP AbbVie EC US00287Y1091 5,160 5,160 393 2.1300
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.